90
Participants
Start Date
May 8, 2017
Primary Completion Date
January 31, 2019
Study Completion Date
February 6, 2019
Active RhinoChill
"Participants will be provided with a RhinoChill® device (Active) and an Intranasal Migraine catheter. Once they have the RhinoChill® device, they are asked to treat the next two of your migraines with the device. This requires a maximum of 10 minute intra-nasal treatment as soon as possible after the start of your migraine.~The participation in the trial will last until 3 migraine headaches have been treated with the RhinoChill® device."
Control Rhinochill
"Participants will be provided with a RhinoChill® device (Sham) and an Intranasal Migraine catheter. Once they have the RhinoChill® device, they are asked to treat the next two of your migraines with the device. This requires a maximum of 10 minute intra-nasal treatment as soon as possible after the start of your migraine.~The participation in the trial will last until 3 migraine headaches have been treated with the RhinoChill® device."
Neurosciences department, Penrith Hospital, Cumbria Partnership NHS Foundation Trust, Penrith
South tees Hospital, Middlesbrough
The Newcastle upon Tyne Hospitals, Newcastle upon Tyne
City Hospital, Sunderland, UK, Sunderland
Collaborators (1)
BrainCool AB
UNKNOWN
Cumbria Partnership NHS Foundation Trust
OTHER